Carisoprodol Tablets — Class III drug recall D-1155-2014
Terminated recall by Mylan Institutional, Inc. (d.b.a. UDL Laboratories), reported 2014-03-19, distributed nationwide. Failed Impurity/degradation Specification
| Recall number | D-1155-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL, United States |
| Recall initiated | 2014-01-28 |
| Classified | 2014-03-12 |
| Reported by FDA | 2014-03-19 |
| Terminated | 2015-06-19 |
| Distributed | Nationwide (US) |
| Quantity | 3,252 cartons |
| Reason classes | specification failure |
| NDC | 51079-0819-20 |
| Lot numbers | 3037463, 3039466, 3040644, 3043463, 3049568 |
| Expiration dates | 2014-02, 2014-03, 2014-04, 2014-06, 2015-03 |
Product
Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20
Reason for recall
Failed Impurity/degradation Specification
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1155-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.